Cushing’s syndrome is the set of clinical manifestations secondary to a chronic excess of glucocorticoids. Bilateral macronodular adrenal hyperplasia with subclinical cortisol secretion is the most common, but its prevalence remains unknown. We describe a case of bilateral macronodular adrenal hyperplasia. This is a 36-year-old female patient who had been consulting for secondary amenorrhea and developing asthenia for 4 months. The clinical examination noted an overweight patient with high blood pressure, facio-trunk obesity, hirsutism and purple stretch marks in the abdomen and thighs. Biologically, hypokalemia at 2.9 meq/l (3.5 - 5.4), normal calcemia at 90 mg/l (85 - 104), fasting blood sugar was 0.84 g/l (0.7 - 1), the tests for minute, low and high dexamethasone suppression test revealed insufficient suppression of cortisol. The cortisoluria collected from the second day to the third day of the high dexamethasone suppression test was at 186 μg/24 h (<60), the ACTH (Pg/ml) was undetectable (6.4 - 49.8). The diagnosis of an independent adrenocorticotrophin (ACTH) Cushing syndrome was made and the adrenal CT scan revealed bilateral macronodular hyperplasia. A bilateral adrenalectomy was performed and a complete remission of Cushing syndrome was achieved. We prescribed to her, hydrocortisone 20 mg/day and alpha-fludrocortisone 25 to 50 μg/day, This medical observation showed that macro-nodular adrenal hyperplasia with overt Cushing syndrome can occur in the third decade of life. Bilateral adrenalectomy has resulted in a complete cure for Cushing’s syndrome, but may be fraught with complications.
References
[1]
Newell-Prince, J., Bertagna, X., Grossman, A.B., et al. (2006) Cushing’s Syndrome. The Lancet, 362, 1605-1617. https://doi.org/10.1016/S0140-6736(06)68699-6
[2]
Stratakis, C.A. (2008) Cushing Syndrome Caused by Adrenocortical Tumors and Hyperplasia (Corticotrophin-Independent Cushing Syndrome). Endocrine Development, 13, 117-132. https://doi.org/10.1159/000134829
[3]
Lacroix, A. (2009) ACTH Independent Macronodular Adrenal Hyperplasia. Best Practice & Research Clinical Endocrinology & Metabolism, 23, 245-259.
https://doi.org/10.1016/j.beem.2008.10.011
[4]
De Venazi, A., Asmar Alencar, G., Bourdeau, I., et al. (2014) Primary Bilateral Macronodular Adrenal Hyperplasia. Current Opinion in Endocrinology, Diabetes and Obesity, 21, 177-184. https://doi.org/10.1097/MED.0000000000000061
[5]
Libé, R., Coste, J., Guingnat, L., et al. (2019) Aberrant Cortisol Regulations in Bilateral Macronodular Adrenal Hyperplasia: A Frequent Finding in a Other Treatment Options. Annales d’Endocrinologie, 80, 32-37.
[6]
Hsiao, H.P., Kirschner, L.S., Bourdeau, I., et al. (2009) Clinical and Genetic Heterogeneity, Overlap with Other Tumor Syndromes, and Atypical Glucocorticoid Hormone Secretion in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Compared with Other Adrenocortical Tumors. The Journal of Clinical Endocrinology & Metabolism, 94, 2930-2937.
https://doi.org/10.1210/jc.2009-0516
[7]
Cohan, P., East, H.E., Galati, S.J., et al. (2019) Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH). The Journal of Clinical Endocrinology & Metabolism, 104, 6279-6290.
https://doi.org/10.1210/jc.2018-02638
[8]
Swain, J.M., Grant, C.S., Schlinkert, R.T., et al. (1998) Corticotropin-Independent Macronodular Adrenal Hyperplasia: A Clinicopathologic Correlation. Archives of Surgery, 133, 541-546. https://doi.org/10.1001/archsurg.133.5.541
[9]
Libé, R., Coste, J., Guingnat, L., et al. (2010) Aberrant Cortisol Regulations in Bilateral Macronodular Adrenal Hyperplasia: A Frequent Finding in a Prospective Study of 32 Patients with Overt or Subclinical Cushing’s Syndrome. European Journal of Endocrinology, 163, 129-138. https://doi.org/10.1530/EJE-10-0195
[10]
Hofland, J., Hofland, L.J., Van Koetveld, P.M., et al. (2013) ACTH-Independent Macronodular Adrenocortical Hyperplasia Reveals Prevalent Aberrant in Vivo and in Vitro Responses to Hormonal Stimuli and Coupling of Arginine-Vasopressin Type 1 A Receptor to 11β-Hydroxylase. Orphanet Journal of Rare Diseases, 8, 142.
https://doi.org/10.1186/1750-1172-8-142
[11]
Assié, G., Libé, R., Espiard, S., et al. (2013) ARMC5 Mutations in Macronodular Adrenal Bilateral Hyperplasia with Cushing’s Syndrome. The New England Journal of Medicine, 369, 2105-2114. https://doi.org/10.1056/NEJMoa1304603
[12]
Alencar, G.A., Lerario, A.M., Nishi, M.Y., et al. (2014) ARMC5 Mutations Are a Frequent Cause of ACTH-Independent Macronodular Adrenal Bilateral Hyperplasia. The Journal of Clinical Endocrinology & Metabolism, 99, 1501-1509.
https://doi.org/10.1210/jc.2013-4237
[13]
Louiset, E., Duparc, C., Young, J., et al. (2013) Intraadrenal Corticotropin in Bilateral Macronodular Adrenal Hyperplasia. The New England Journal of Medicine, 369, 2115-2125. https://doi.org/10.1056/NEJMoa1215245
[14]
El Ghorayeb, N., Bourdeau, I. and Lacroix, A. (2015) Multiple Aberrant Hormone Receptors in Cushing’s Syndrome. European Journal of Endocrinology, 173, M45-M60.
https://doi.org/10.1530/EJE-15-0200
[15]
Mircescu, H., Jilwan, J., N’Diaye, N., Bourdeau, I., Tremblay, J., Hamet, P., et al. (2000) Are Ectopic or Abnormal Membrane Hormone Receptors Frequently Present in Adrenal Cushing’s Syndrome? The Journal of Clinical Endocrinology & Metabolism, 85, 3531-3536. https://doi.org/10.1210/jc.85.10.3531
[16]
Drougat, L, Espiard, S. and Bertherat, J. (2015) Genetics of Primary Bilateral Macronodular Adrenal Hyperplasia: A Model for Early Diagnosis of Cushing’s Syndrome? European Journal of Endocrinology, 173, M121-M131.
https://doi.org/10.1530/EJE-15-0532
[17]
Nieman, L.K., Chrousous, G.P., Kellner, C., et al. (1985) Successful Treatment of Cusching’s Syndrome with the Glucocorticoid Antagonist RU486. The Journal of Clinical Endocrinology & Metabolism, 61, 536-540.
https://doi.org/10.1210/jcem-61-3-536
[18]
Ritzel, K., Beuschlein, F., Mickisch, A., et al. (2013) Outcome of Bilateral Adrenalectomy in Cushing’s Syndrome: A Systematic Review. The Journal of Clinical Endocrinology & Metabolism, 98, 3939-3948.
https://doi.org/10.1210/jc.2013-1470
[19]
Aggarwal, S., Yadav, K., Sharma, A.P., et al. (2013) Laparoscopic Bilateral Transperitoneal Adrenalectomy for Cushing’s Syndrome: Surgical Challenges and Lessons Learnt. Surgical Laparoscopy Endoscopy & Percutaneous Techniques, 23, 324-328. https://doi.org/10.1097/SLE.0b013e318290126d
[20]
Sheikh-Ahmad, M., Dickstein, G., Matter, I., et al. (2019) Unilateral Adrenalectomy for Primary Bilateral Macronodular Adrenal Hyperplasia: Analysis of 71 Cases. Experimental and Clinical Endocrinology and Diabetes.
https://doi.org/10.1055/a-0998-7884